In 2003, Morton founded and was appointed CEO of Zeneus Pharma Ltd (2003), a European speciality oncology and critical care company. He sold Zeneus to Cephalon (Nasdaq: CEPH) for $360 million ...

Ellipses Pharma is committed to pursuing a collaborative approach to advancing cancer treatments. We build relationships with leading research institutions, charitable bodies, commercial pharma, biotech companies and outsourced development providers around the world.

Zeneus Pharma Ltd. provides pharmaceutical products. It offers license to late-stage development, pre and post-approval, and marketing services across Europe for specialty hospital medicines. The company was founded in 2004 by Bryan Morton and is headquartered in Oxford, UK. with RelSci Contact Aggregator. Relationship Data from the RelSci API.

Dr Tim Corn is the Company's Chief Medical Officer. Dr Corn was previously with Glaxo, MHRA, Elan and Zeneus Pharma. Zoe Evans, Legal Counsel and Company Secretary, has previous experience with companies in the sector including PowderJect Pharmaceuticals, Chiron Vaccines, Zeneus Pharma and Cephalon.

Founder of Circassia Group Plc, Steven Harris is a British businessperson who has been at the head of 5 different companies and is Chairman of Synchrony Pharma Ltd. and Chief Executive Officer of Circassia Group Plc. Mr. Harris is also on the board of Adiga Life Sciences, Inc., Headington School Oxford Ltd., Circassia Pharma Ltd. and Circassia Pharmaceuticals, Inc. and Member of Association …

Steven has extensive experience of leading specialty pharmaceutical companies. Prior to co-founding Circassia, he was a founding member of the private equity backed management team that grew Zeneus Pharma Limited into a successful specialty pharmaceutical company and managed its acquisition by Cephalon Inc. (now part of Teva Pharmaceutical ...

Cephalon acquires UK's Zeneus Pharma. 6 December 2005 Company restructures. US-based Cephalon has announced that has agreed to acquire the holding company of Zeneus Pharma Limited for $360 million. Europe-based Zeneus Pharma will become a fully owned subsidiary of Cephalon. The company said that the acquisition will allow the firm to expand its ...

A New Hope For The Treatment Of Life-Threatening Acute-on-Chronic Liver Failure Akaza Bioscience is a biopharmaceutical company pioneering the development of Resatorvid (TAK-242), a novel immunological therapy for the treatment of Acute-on-Chronic Liver Failure (ACLF). Get in touch ACLF Is A Rapidly Progressive, Life-Threatening Disease With No Specific, Effective Medical Treatment Acute …

The company ZENEUS PHARMA (IRELAND) LTD, is a Wholesaler, which operates in the Pharmaceutical products industry. It is based in Bray, Ireland . Other companies in the same industry: HAYDSWISS SÀRL LABORATOIRE NUTERGIA ATLANTIC CHEMICALS TRADING SFM HOSPITAL PRODUCTS ...

The EUSA Pharma Board of Directors is highly experienced in investment and pharmaceutical management, and provides strategic support as well as an extensive industry network. Bryan Morton founded EUSA Pharma, Inc in 2006. A transatlantic specialty pharmaceutical company focused on oncology and critical care. Bryan was the President and CEO of ...

Zeneus Pharma Ltd 2004 - 2006 2 years. Regional Manager Parke Davis & Co 1992 - 1999 7 years. Education York St. John University York St. John University 2:1 Sports Physiology. 1986 - 1990. Groups Pharma SFE Pharma SFE -Pharma KAM ...

Dr Corn was previously with Glaxo, MHRA, Elan and Zeneus Pharma. Zoe Evans, Legal Counsel and Company Secretary, has previous experience with companies in …

Sopherion Therapeutics LLC is a specialty biopharmaceutical company with an exclusive licensing. agreement with Zeneus Pharma Ltd., now Cephalon, Inc., for the commercialization of Myocet™ (a liposome-encapsulated doxorubicin-citrate complex) in the United States and Canada.

Yamanouchi – Yamanouchi Pharma Ltd Zeal – G. H. Zeal Ltd Zeneus – Zeneus Pharma Ltd Zeroderma – Zeroderma Ltd ZLB – ZLB Bioplasma UK Ltd ZLB Behring – ZLB Behring UK Ltd source from wikipedia.org. Posted by Linux at 4:57 AM No …

Handshakes: Amgen will purchase Abgenix for $2.2 billion, Cephalon will acquire U.K.'s Zeneus Pharma — opening the door for Cephalon's entry into the European oncology market — and Serono, Europe's third largest biotech, is considering a buyout, with potential suitors including Pfizer, Novartis, GlaxoSmithKline, and Sanofi-Aventis ...

In his past career he was Chief Medical Officer of Zeneus Pharma Ltd., Chief Medical Officer for EUSA Pharma, Inc., Chief Medical Officer for Jazz Pharmaceuticals UK Ltd., Chief Medical Officer at Eusa Pharma International Ltd., Principal at Elan Corp. Plc, Principal at Athena Neurosciences LLC and Principal at Organon Pharma (UK) Ltd.

Zeneus Pharma Limited Feb 2004 - Nov 2005 1 year 10 months. Oxford, United Kingdom Leader of Regulatory Affairs Group in Central European Office and Regulatory Managers in each EU country office. Responsible for regulatory strategy and review of all in-licensing opportunities. Regulatory Compliance and strategic considerations for supply chain ...

Zeneus Pharma is an excellent strategic fit for our company." This marks the latest in a growing stream of consolidation deals in Europe's biotechnology sector, signifying the current need of the region's baby biotechs to add muscle to their operations in order to speed up the process of getting their candidates to market.

In 2004, Sopherion entered into an exclusive licensing agreement with Zeneus Pharma Ltd., now Cephalon, Inc. for the future commercialization of Myocet in …

Cathrin has also held numerous non-executive positions, including at the NHS (Strategic Health Authority for Greater London), Circassia Pharmaceuticals Ltd, Icon Plc., Qualitest Inc and Zeneus Pharma Ltd.

1.1. Cancer Treatment Today. Cancer is reported as the second leading cause of death in the US and accounts for ~25% of all deaths [].Even more serious is the recent projection by the World Health Organization, which anticipates total cancer cases will more than double by the year 2030 from the 12.4 million new cases seen in 2008 [].Despite the fact that scientific understanding of the ...

Zeneus Pharma Ltd. provides pharmaceutical products. It offers license to late-stage development, pre and post-approval, and marketing services across Europe for specialty hospital medicines. The company was founded in 2004 by Bryan Morton and is headquartered in Oxford, UK.

Ms Petty has also held numerous non-executive positions, including at the NHS (Strategic Health Authority for Greater London), Circassia Pharmaceuticals Ltd, Icon Plc., Qualitest Inc and Zeneus Pharma Ltd..

He was formerly Chief Medical Officer at EUSA Pharma International, a division of Jazz Pharmaceuticals, at EUSA Pharma Inc and at Zeneus Pharma, as well as Non-executive Director at Circassia Pharmaceuticals plc, Neurocentrx Pharma Ltd and HRA Pharma.

Parcourez les 42505 fournisseurs potentiels du secteur exportation sur Europages, plateforme de sourcing B2B à l'international.- pg-1327

Most recently Dennise held the position of Country Manager, leading the Irish affiliate of IPSEN Pharmaceuticals and was responsible for all aspects of the business. Prior to this Dennise also held CEO/MD and senior leadership roles with Pfizer, Hospira, Zeneus, Viatris and other pharmaceutical companies both in Ireland and Europe.

Private Company Edition: The industry raised $28bn in venture capital through the third quarter, breaking the record $27.4bn raised last year. Also, big pharmas backed a start-up lab in Israel, plus mega-rounds for CinCor Pharma ($143m) and Rectify Pharmaceuticals …

The other companies that complete this list of top 200 best pharmaceutical companies in UK are as follows: KoRa – KoRa Healthcare Ltd. Kyowa Hakko – Kyowa Hakko UK Ltd. LAB – Laboratories for Applied Biology. Lederie – Wyeth. Gluten Free Foods Ltd – Gluten Free Foods Ltd. Goldshield – Goldshield Pharmaceuticals Ltd.

Find mental health logo image and details. We not only have mental health logos but many more! Logos for editorial use are suitable to illustrate news articles, but are not cleared for commercial use.

People. Managed by a team with a track record of success, with the support of a Board of blue-chip investors, one of VHsquared's assets is the strength of its people.

Zeneus Pharma General Information Description. Operator of a biopharmaceutical company. The company provides substantial clinical, regulatory, sales and marketing operations in Europe.

Zeneus Pharma Limited Zeneus Pharma is a European biopharmaceutical company with substantial clinical, regulatory, sales and marketing operations in Europe with worldwide sales through partner agreements. Zeneus Pharma has a broad portfolio of specialist-marketed products currently focused on oncology and critical care.

Prior to this and between July 2004 and October 2011, Simon held several senior positions in the areas of Business Development, Corporate Development and Emerging Markets with Cephalon Inc. (formerly known as Zeneus Pharma Ltd), EUSA Pharma Ltd. (now Jazz Pharmaceuticals Inc.) and Takeda Pharmaceutical Company Limited.

Zeneus Holdings is the parent company of Zeneus Pharma Ltd., a European biopharmaceutical company. The transaction is expected to accelerate Cephalon's entry into the European oncology market and to increase the company's presence in Europe's five largest pharmaceutical markets. Cephalon anticipates the deal will generate about $100 ...

Assignors: LIPOSOME COMPANY, INC., THE Assigned to MEDEUS UK LIMITED reassignment MEDEUS UK LIMITED REDACTED LICENSE AGREEMENT Assignors: ELAN PHARMACEUTICALS, INC. Assigned to CEPHALON LIMITED reassignment CEPHALON LIMITED CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: ZENEUS PHARMA LIMITED